Digoxin
Digoxin is used for treating heart failure and slowing the heart rate in patients with chronic atrial fibrillation, a type of abnormal heart rhythm.
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $48.00 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $64.00 $59.00 (8%) | 🛒 Add to cart |
| 180 | $0.46 | $96.00 $83.00 (14%) | 🛒 Add to cart |
| 270 | $0.43 | $144.00 $117.00 (19%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $192.00 $152.00 (21%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Asacol: Targeted Relief for Ulcerative Colitis Symptoms
Asacol (mesalamine) is a prescription medication specifically formulated for the treatment of mild to moderate ulcerative colitis. It belongs to the class of aminosalicylates and works locally in the colon to reduce inflammation, helping to induce and maintain remission. This delayed-release formulation ensures the active ingredient is delivered directly to the site of disease activity, minimizing systemic absorption and optimizing therapeutic efficacy for appropriate patients under medical supervision. Features Active ingredient: Mesalamine (5-aminosalicylic acid or 5-ASA) Formulation: Delayed-release tablets designed for targeted colonic release Available strengths: 400 mg and 800 mg delayed-release tablets pH-dependent coating that dissolves at pH ≥7, typically in the terminal ileum and colon Designed to minimize systemic absorption while maximizing local anti-inflammatory effects Benefits Effectively reduces inflammation in the colon to control ulcerative colitis symptoms Helps achieve and maintain clinical remission in mild to moderate cases Targeted delivery system minimizes systemic exposure and potential side effects Demonstrated efficacy in reducing relapse rates when used as maintenance therapy Generally well-tolerated with a favorable safety profile compared to systemic therapies Convenient oral administration that supports long-term treatment adherence Common use Asacol is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older.
Colchicine: Targeted Relief for Gout and Inflammation
Colchicine is a time-tested alkaloid medication derived from the autumn crocus (Colchicum autumnale). It represents a cornerstone in the management of acute gout flares and familial Mediterranean fever (FMF), offering a mechanism of action distinct from NSAIDs or corticosteroids. Its primary value lies in its specific anti-inflammatory effects, targeting neutrophil motility and cytokine release without acting as a general analgesic or antipyretic. This profile details its expert use, pharmacological properties, and essential clinical considerations for safe and effective administration.
Deltasone: Potent Systemic Corticosteroid for Inflammation Control
Deltasone is the brand name for the systemic corticosteroid prednisone, a cornerstone medication in managing a wide spectrum of inflammatory and autoimmune conditions. It functions as a potent immunosuppressant and anti-inflammatory agent, mimicking the effects of hormones naturally produced by the adrenal glands. By modulating the body’s immune response, it effectively reduces inflammation, alleviates pain, and suppresses inappropriate immune activity, providing critical therapeutic relief where other treatments may fall short. This makes it an indispensable tool for physicians in specialties ranging from rheumatology to pulmonology and hematology.
Hydroxychloroquine: Immune Modulation for Chronic Conditions
Hydroxychloroquine is an oral disease-modifying antirheumatic drug (DMARD) with immunomodulatory properties, widely prescribed for autoimmune disorders and malaria prophylaxis. This antimalarial quinoline derivative demonstrates significant efficacy in managing inflammatory pathways through complex mechanisms involving Toll-like receptor signaling and cytokine modulation. Clinical applications extend beyond its original antimalarial indications to chronic autoimmune conditions requiring long-term immunoregulation. Features Chemical classification: 4-Aminoquinoline compound Available formulations: 200mg and 400mg oral tablets Mechanism: Lysosomal pH alteration and autophagy inhibition Bioavailability: Approximately 74% following oral administration Half-life: 40-50 days in plasma Metabolism: Hepatic via cytochrome P450 enzymes Excretion: Primarily renal (60%) with partial biliary elimination Benefits Provides sustained suppression of autoimmune activity through immunomodulatory mechanisms Reduces disease progression and joint damage in inflammatory arthritides Demonstrates steroid-sparing effects in systemic lupus erythematosus management Offers convenient once-daily dosing regimen for improved adherence Shows favorable long-term safety profile compared to biologic DMARDs Provides cost-effective disease modification in resource-limited settings Common use Hydroxychloroquine is primarily indicated for the treatment of uncomplicated malaria caused by Plasmodium vivax, P.
Medrol: Potent Glucocorticoid for Effective Inflammation Control
Medrol (methylprednisolone) is a synthetic glucocorticoid corticosteroid medication renowned for its potent anti-inflammatory and immunosuppressive properties. It is a cornerstone therapy in managing a wide spectrum of inflammatory and autoimmune conditions, offering rapid and significant symptomatic relief. By modulating the body’s immune response, it effectively reduces swelling, redness, warmth, and pain associated with numerous disorders. Its predictable pharmacokinetic profile and well-established dosing protocols make it a trusted agent in both acute and chronic therapeutic regimens under expert medical supervision.
Plaquenil: Advanced Hydroxychloroquine for Autoimmune Management
Plaquenil (hydroxychloroquine sulfate) is a disease-modifying antirheumatic drug (DMARD) widely prescribed for the management of autoimmune conditions such as systemic lupus erythematosus and rheumatoid arthritis. Its immunomodulatory and anti-inflammatory properties help reduce disease activity, prevent flares, and protect against long-term organ damage. By interfering with antigen processing and cytokine production, Plaquenil offers a well-tolerated, foundational therapy option for patients requiring sustained immunosuppression with a favorable safety profile relative to other agents.
Advanced Diclofenac Emulgel for Targeted Pain Relief
Diclofenac Emulgel represents a significant advancement in topical analgesic therapy, combining the proven efficacy of diclofenac with innovative emulsion gel technology. This pharmaceutical formulation is specifically engineered to provide targeted relief from musculoskeletal pain and inflammation while minimizing systemic exposure. Developed through extensive clinical research, this emulgel offers healthcare professionals and patients a sophisticated alternative to oral NSAIDs, particularly for localized conditions where direct application is advantageous. Its unique carrier system ensures optimal drug penetration and bioavailability at the site of application.
Arava: Targeted Symptom Control for Rheumatoid Arthritis
Arava (leflunomide) is a disease-modifying antirheumatic drug (DMARD) specifically engineered to manage the symptoms and progression of rheumatoid arthritis. By selectively inhibiting pyrimidine synthesis in activated lymphocytes, it reduces inflammation, minimizes joint damage, and helps preserve physical function. This oral treatment offers a convenient therapeutic option for adults with moderate to severe active rheumatoid arthritis, providing sustained relief and improving quality of life. Clinical studies demonstrate its efficacy in reducing tender and swollen joint counts and slowing radiographic progression.
Arcoxia: Targeted Relief for Chronic Osteoarthritis and Pain
Arcoxia (etoricoxib) is a prescription medication belonging to the class of drugs known as selective COX-2 inhibitors, a type of nonsteroidal anti-inflammatory drug (NSAID). It is specifically engineered to provide potent anti-inflammatory and analgesic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for pain and inflammation, while largely sparing the COX-1 enzyme involved in protecting the stomach lining. This mechanism offers a refined approach to managing chronic musculoskeletal conditions, particularly osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute gouty arthritis and primary dysmenorrhea.